chr2-168924730-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_003742.4(ABCB11):c.3692G>A(p.Arg1231Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,613,232 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000055 ( 0 hom. )
Consequence
ABCB11
NM_003742.4 missense
NM_003742.4 missense
Scores
15
3
1
Clinical Significance
Conservation
PhyloP100: 7.91
Genes affected
ABCB11 (HGNC:42): (ATP binding cassette subfamily B member 11) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is the major canalicular bile salt export pump in man. Mutations in this gene cause a form of progressive familial intrahepatic cholestases which are a group of inherited disorders with severe cholestatic liver disease from early infancy. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PM1
In a domain ABC transporter 2 (size 238) in uniprot entity ABCBB_HUMAN there are 7 pathogenic changes around while only 0 benign (100%) in NM_003742.4
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.991
PP5
Variant 2-168924730-C-T is Pathogenic according to our data. Variant chr2-168924730-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 287364.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCB11 | NM_003742.4 | c.3692G>A | p.Arg1231Gln | missense_variant | 27/28 | ENST00000650372.1 | NP_003733.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCB11 | ENST00000650372.1 | c.3692G>A | p.Arg1231Gln | missense_variant | 27/28 | NM_003742.4 | ENSP00000497931.1 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151650Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
151650
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249278Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135234
GnomAD3 exomes
AF:
AC:
3
AN:
249278
Hom.:
AF XY:
AC XY:
2
AN XY:
135234
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461582Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727086
GnomAD4 exome
AF:
AC:
8
AN:
1461582
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
727086
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151650Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74022
GnomAD4 genome
AF:
AC:
1
AN:
151650
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74022
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 05, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 23, 2022 | Reported as a single heterozygous variant in association with benign recurrent intrahepatic cholestasis (Drge et al., 2017); Published functional studies demonstrate a damaging effect on protein maturity and cell surface expression (Byrne et al., 2009, Naoi et al., 2014); This variant is associated with the following publications: (PMID: 31589614, 24530123, 15317749, 21490445, 32808743, 19101985, 29104077, 34961929, 24991443, 34016879, 18395098, 28733223) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1231 of the ABCB11 protein (p.Arg1231Gln). This variant is present in population databases (rs758069019, gnomAD 0.007%). This missense change has been observed in individuals with cholestasis (PMID: 15317749, 18395098, 24530123, 24991443). ClinVar contains an entry for this variant (Variation ID: 287364). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCB11 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects ABCB11 function (PMID: 19101985, 24530123). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | ABCB11: PM3:Strong, PM2, PM5, PP3, PP4, PS3:Supporting - |
Progressive familial intrahepatic cholestasis type 2 Pathogenic:2
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Oct 16, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Rolfs Rare Disease Consulting, Rolfs Consulting Und Verwaltungs GmbH | Jan 01, 2020 | - - |
Benign recurrent intrahepatic cholestasis type 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 28, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Pathogenic
D;D;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M;M;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.;.
REVEL
Pathogenic
Sift
Pathogenic
D;.;.
Sift4G
Pathogenic
D;.;.
Polyphen
D;D;.
Vest4
MutPred
Loss of MoRF binding (P = 0.0189);Loss of MoRF binding (P = 0.0189);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at